[ad_1]
Original title: Good news, 90% price reduction! 1 million people benefited! This “national group purchase” has been launched in 18 provinces, regions and cities!
Summary
[Buenasnoticiasreduccióndepreciodel90%!1millóndepersonasbeneficiadas!This”compragrupalnacional”sehalanzadoen18provinciasregionesyciudades!】Hoyelestadoorganizaelprimerlotede18provincias(regions)paraimplementarlaadquisicióncentralizadadestentscoronariosincluyendoBeijingTianjinHebeiLiaoningJilinHeilongjiangJiangsuZhejiangFujianShandongHunanGuangdongHainanGuizhouYunnanGansuQinghaiXinjiang(incluidoelCuerpo)Elinventariolocaldeproductosseleccionadosenelprimerlotede18provinciasciudades(regions)alcanzóunpromediodel33%delvolumendecompraacordadoquepuedesatisfacerlasnecesidadesdelasinstitucionesmédicasenelprimermes(FinanzasCCTV)[¡Buenasnoticiasreduccióndepreciodel90%!¡1millóndepersonasbeneficiadas!¡Esta”compragrupalnacional”sehalanzadoen18provinciasregionesyciudades!】Hoyelestadoorganizaelprimerlotede18provincias(regiones)paraimplementarlaadquisicióncentralizadadestentscoronariosincluyendoBeijingTianjinHebeiLiaoningJilinHeilongjiangJiangsuZhejiangFujianShandongHunanGuangdongHainanGuizhouYunnanGansuQinghaiXinjiang(incluidoelCuerpo)Elinventariolocaldeproductosseleccionadosenelprimerlotede18provinciasciudades(regiones)alcanzóunpromediodel33%delvolumendecompraacordadoquepuedesatisfacerlasnecesidadesdelasinstitucionesmédicasenelprimermes(FinanzasCCTV)
Today (January 1), the results of the centralized procurement of coronary stents by the national organization were officially implemented in 18 provinces, autonomous regions and municipalities, including Beijing, Tianjin and Liaoning. The patients in these settings used centralized coronary stents.
National Health Insurance Administration: The collection of coronary stents will be implanted in 18 provinces, autonomous communities and municipalities
Today, the state organizes the first batch of 18 provinces and cities (regions) to implement the centralized procurement of coronary stents, including Beijing, Tianjin, Hebei, Liaoning, Jilin, Heilongjiang, Jiangsu, Zhejiang, Fujian, Shandong, Hunan, Guangdong, Hainan. , Guizhou, Yunnan, Gansu, Qinghai, Xinjiang (including the Corps). Selected from the first batch of 18 provinces and cities (districts) to landproductNative libraryValuesMid-range agreementPurchase amount33% of the total, which can cover the needs of medical institutions in the first monthdemand. The remaining provinces will be implemented in January 2021 and will strive to allow patients to use the coronary stent after collection.
National Health Insurance AdministrationpriceAnd Dong Chaohui, Director of the Bidding and Procurement Department:For patients, the first is the decrease in medical burden: a chromium alloy stent will be reduced by an average of 12,000 yuan. If 1.5 stents are used for an operation, it can be estimated that the individual burden of an insured person saves between 7,000 and 8,000 yuan. We collected chromium alloy stents this time, which is more in line with the development of clinical use. We hope that with centralized procurement, the price will go down and coronary stents can be used for emergency patients. For non-emergency surgeries, the original possibilityOvermarketingThe abuse caused will also be reduced.
The national collection of coronary stents benefited more than 1 million patients
How many coronary stents will be harvested this time?Common peopleBenefit? How much will you save?
The national coronary stent centralized procurement organization produced the selection results in early November 2020.The average price of the 10 selected varieties fell from 13,000 yuan to around 700 yuan, a decrease of more than 90% and savings estimated cost of 11.7 billion yuan.After the selection results were announced, all localities and departments carried out various preparations for the implementationjobsThe health insurance department oversees the selection.companyHang the network at the selected priceSales, Medical institutions buy and use according to the selected price, and at the same time introduce a health insurance payment policy to ensure that the reduced price of coronary stents can be used and is available to patients.Refund. In China, about 1 million coronary heart disease patients have cardiac stents implanted each year, and patients can use selected cardiac stents, which will greatly reduce the burden of medical treatment for patients.
Chen Jinfu, deputy director of the National Health Insurance Administration:Some people are also concerned that companies are taking shortcuts after the price is lowered. In this sense, we have a complete system design. The first company isqualityFirstresponsibilityPeople; second, there is quality at the threshold of recruitmentWarrantyThe third part of the hiring process must have a quality commitment, the fourth government has quality supervision, the most important, I think the companyqualitydevelopment of,BrandIn terms of maintenance, quality is taken as life.
Dong Chaohui, Director of the Pricing and Bidding and Purchasing Department of the National Health Insurance Administration:The next step we need to do is to summarize the existing experience and further optimize the procurement rules.Because it is still in the exploratory stage, we mainly consider those that are most widely used clinically, the purchase amount is relatively large and the technology is relatively maturemarketProducts with relatively sufficient competition are given priority to be included in the scope of centralized procurement.
(Source: CCTV Finance)
(Responsible editor: DF512)
I solemnly declare: The purpose of this information is to spread more information, and it has nothing to do with this booth.
[ad_2]